Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - SHORT-TERM DEBT
Short-term Debt APLS - Apellis Pharmaceuticals, Inc.
6.44 M
LAST VALUE
25.11%
2 YEAR CAGR
31.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR